Molina Healthcare, Inc. (NYSE:MOH) Shares Sold by Vident Advisory LLC

Vident Advisory LLC trimmed its stake in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 78.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 979 shares of the company's stock after selling 3,602 shares during the period. Vident Advisory LLC's holdings in Molina Healthcare were worth $285,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also added to or reduced their stakes in the company. Colonial Trust Co SC boosted its holdings in shares of Molina Healthcare by 930.0% in the fourth quarter. Colonial Trust Co SC now owns 103 shares of the company's stock valued at $30,000 after purchasing an additional 93 shares during the period. Wingate Wealth Advisors Inc. purchased a new position in Molina Healthcare during the 4th quarter worth $52,000. Hurley Capital LLC bought a new stake in Molina Healthcare during the 4th quarter valued at $55,000. EverSource Wealth Advisors LLC lifted its holdings in shares of Molina Healthcare by 81.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock worth $57,000 after buying an additional 88 shares during the period. Finally, Whittier Trust Co. of Nevada Inc. grew its position in shares of Molina Healthcare by 337.0% during the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company's stock worth $58,000 after buying an additional 155 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors.

Molina Healthcare Stock Down 2.5%

Shares of MOH traded down $7.64 during midday trading on Monday, hitting $297.40. 604,429 shares of the company's stock traded hands, compared to its average volume of 684,425. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69. The stock has a market capitalization of $16.12 billion, a price-to-earnings ratio of 14.56, a price-to-earnings-growth ratio of 1.06 and a beta of 0.63. Molina Healthcare, Inc. has a 1 year low of $262.32 and a 1 year high of $365.23. The firm's fifty day moving average is $323.10 and its 200-day moving average is $307.29.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, beating analysts' consensus estimates of $5.96 by $0.12. The company had revenue of $11.15 billion during the quarter, compared to analysts' expectations of $10.86 billion. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The firm's revenue was up 12.2% compared to the same quarter last year. During the same period last year, the business posted $5.73 earnings per share. As a group, sell-side analysts anticipate that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.

Insider Activity at Molina Healthcare

In other news, CEO Joseph M. Zubretsky sold 87,500 shares of the business's stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the sale, the chief executive officer now directly owns 257,715 shares of the company's stock, valued at $82,484,262.90. The trade was a 25.35% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Richard M. Schapiro sold 669 shares of the firm's stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total value of $214,414.50. Following the completion of the transaction, the director now owns 11,244 shares of the company's stock, valued at $3,603,702. This trade represents a 5.62% decrease in their position. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research firms recently weighed in on MOH. Truist Financial lifted their price objective on Molina Healthcare from $340.00 to $400.00 and gave the company a "buy" rating in a report on Friday, April 11th. Barclays cut their target price on shares of Molina Healthcare from $362.00 to $351.00 and set an "equal weight" rating on the stock in a research report on Monday. Stephens reaffirmed an "equal weight" rating and issued a $345.00 price target on shares of Molina Healthcare in a research report on Thursday, February 6th. Mizuho lifted their price objective on shares of Molina Healthcare from $376.00 to $400.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Finally, Wells Fargo & Company upgraded Molina Healthcare from an "equal weight" rating to an "overweight" rating and upped their target price for the stock from $295.00 to $372.00 in a report on Wednesday, March 5th. Nine equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $364.54.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.